Company Aggregate Debt: milestonescientific.com (MLSS)

Symbol and logo of brand Milestone Scientific Inc. (MLSS)

The slow adoption of painless injections in dentistry is hindering the expansion of Milestone Scientific (MLSS). The organization's debt profile reflects the market's reaction to these challenges, with the value stabilizing at 0.00. Steady revenue from consumables supports the business, although the outsourcing of mass instrument production creates a significant dependence on external quality control and third-party vendors.

Company Aggregate Debts: Milestone Scientific (MLSS) for 07/04/2022 - 10/26/2026

Metric breakdowns and analytics for Milestone Scientific Inc. (MLSS)

- price and consensus price forecast:
Market Price Milestone Scientific Corporation|MLSS - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Milestone Scientific Corp|MLSS - Enterprise Value
- book capitalization data:
Net Assets per Share Milestone Scientific|MLSS - Book Capitalization|Market Cap to Net Assets Ratio milestonescientific.com|MLSS - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Milestone Scientific|MLSS - Long-Term Debt to Equity|Short-Term Debt to Equity Milestone Scientific Inc|MLSS - Company Total Debt|Debt to Net Assets Ratio Milestone Scientific Corp
Basic company analysis:MLSS Milestone Scientific Corporation
Product sample of Milestone Scientific Inc

Investors are assessing the resilience of Milestone Scientific (MLSS) through an analysis of debt load, which aggregates all borrowed funds to determine the real cost of operational stability. This total liabilities metric reflects the loan refinancing process, which is critical given the volatile adoption of anesthesia systems in dental practices. The trend line captures how effectively Milestone Scientific (MLSS) balances leveraged capital amid limited revenue growth rates.

Key competitors

Company Cumulative Debt Intuitive Corp (ISRG)|DHR - Company Aggregate Debts|Company Aggregate Debt bd.com BDX|Company Aggregate Debts STE (STERIS)|WST - Company Total Debt Obligations|BAX (Baxter Corp) - Company Aggregate Debts|Masimo Inc. (MASI) - Company Total Debt|STVN (Stevanato Group S.p.A.) - Company Aggregate Debts|Company Aggregate Debts TFX|Company Debts Merit Medical (MMSI)|Company Debts Envista Holdings Corporation NVST|Company Total Debt ICU Medical Corp|Aggregate Debt Obligations Sirona Dental Systems XRAY|Company Aggregate Debts LMAT (LeMaitre Vascular, Inc.)|ATRC: Company Total Debt Obligations|Company Debts STAAR Surgical|NAGE (ChromaDex Corporation) - Company Aggregate Debt|ZIMV: Company Debts|Company Total Debt Obligations AngioDynamics Inc. (ANGO)|Company Total Debt Cerus Corporation|Company Cumulative Indebtedness TKNO (teknova.com)|Company Debts Monogram Orthopedics|STSS - Aggregate Debt Obligations|InfuSystem Inc - Company Total Debt|UTMD: Company Aggregate Debts|KRMD (korumedical.com) - Company Debts|nyxoah.com (NYXH) - Company Total Debt|Company Aggregate Debts MBOT (Microbot Medical)|Company Cumulative Debt PDEX|Company Debts Zentek Limited ZTEK|Company Aggregate Debt Elutia Corporation ELUT|Company Total Debt NEXGEL, Inc. (NXGL)|Retractable Technologies Inc. - Company Cumulative Indebtedness|Company Debts HBIO (Harvard Bioscience)|FEMY: Company Total Debt Obligations|MHUA (meihuamed.com) - Company Debts|Predictive Oncology Inc. (POAI) - Company Total Debt|CJMB: Company Aggregate Debts|Company Total Debt Obligations ATRI|Company Debts NeuroMetrix (NURO)